Search - tctmd.com

Displaying 141 - 160 of 252

Sort: Relevancy | Date

Presentation

Costs Associated With Access Site and Same-Day Discharge Among Medicare Beneficiaries Undergoing PCI

February 17, 2017

Presentation JIM 2017

Safety and Efficacy of Fluorinated Permanent Polymer DES

Presenter: Tullio Palmerini

February 10, 2017

Presentation JIM 2017

Innovative Percutaneous Approaches to Mitral Valve Repair: From Early Trials to Real World Experience

Presenter: Ted Feldman

February 10, 2017

Presentation Mitral Valve 2017

Data & Innovation at ETH... from the Perspective of Medical Research

Presenter: Detlef Günther

February 06, 2017

Presentation

Association of Rapid Care Process Implementation With Reperfusion Times Across STEMI Networks

Presenter: Christopher Fordyce

January 18, 2017

Presentation Cardiovascular Interventions 2016

What's Wrong with MOC and re-certification?

Presenter: Paul S. Teirstein

November 11, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: PARTNER I 5-YEAR Echo and PARTNER II Quality of Life

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Ganesh Manoharan

November 01, 2016

Presentation TCT 2016

How Much Radiation Do I Use Compared to Others? Review of Reference Levels and QA Policies

Presenter: Stephen Balter, Donald L. Miller

November 01, 2016

Presentation TCT 2016

Hot: Is High Dose Due to Operator Preferences or Patient Characteristics?

Presenter: Stephen Balter, Sanjog Kalra

November 01, 2016

Presentation TCT 2016

Ethics of Irradiating Patients and Staff

Presenter: Stephen Balter, Charles E. Chambers

November 01, 2016

Presentation TCT 2016

PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Presenter: Gregg W. Stone, Philippe Pibarot, David J. Cohen

November 01, 2016

Presentation TCT 2016

Strengths and Limitations of Post-Approval Registries as Vehicles to Track Safety and Inform Device Label Expansion

Presenter: Owen Faris, Mitchell W. Krucoff, David R. Holmes Jr.

October 31, 2016

Presentation TCT 2016

Risk Scores: Development, Validation, Utility, and Limitations (With Case Studies: Framingham, TIMI/GRACE, CHADS/HASBLED, DAPT, and Others)

Presenter: Scott Berry, Stuart J. Pocock, Ajay J. Kirtane

October 30, 2016

Presentation TCT 2016

Mediation Analysis: A Method to Assign Attributable Risk

Presenter: Scott Berry, Stuart J. Pocock, Bjorn Redfors

October 30, 2016

Presentation TCT 2016

Surrogate Endpoints: Construction, Validation, and Trustiness

Presenter: Scott Berry, Stuart J. Pocock, William S. Weintraub

October 30, 2016

Presentation TCT 2016

Accounting for the Risk of Competing Events

Presenter: Scott Berry, Stuart J. Pocock, Peter Juni

October 30, 2016

Presentation TCT 2016

Analyzing Repeat Events

Presenter: Scott Berry, Stuart J. Pocock, Eugene H. Blackstone

October 30, 2016

Presentation TCT 2016

Limitations of Composite Endpoints and Strategies for Hierarchical Testing

Presenter: Scott Berry, Stuart J. Pocock, Jan G. P. Tijssen

October 30, 2016

Presentation TCT 2016

Strengths and Limitations of Meta-analysis: Standard, Network and Bayesian Techniques, and the Value of Individual Patient-level Data Pooling

Presenter: Ori Ben-Yehuda, Tullio Palmerini, Giuseppe Biondi-Zoccai

October 30, 2016

Presentation TCT 2016

When Are Randomized Trials Not Enough, and Can Observational Data Reliably Inform Comparative Effectiveness Decisions?

Presenter: Eugene H. Blackstone, Robert W. Yeh, Robert A. Harrington

October 30, 2016

Advertisement

Costs Associated With Access Site and Same-Day Discharge Among Medicare Beneficiaries Undergoing PCI

Safety and Efficacy of Fluorinated Permanent Polymer DES

Innovative Percutaneous Approaches to Mitral Valve Repair: From Early Trials to Real World Experience

Data & Innovation at ETH... from the Perspective of Medical Research

Association of Rapid Care Process Implementation With Reperfusion Times Across STEMI Networks

What's Wrong with MOC and re-certification?

Highlights (and my Interpretations) From: PARTNER I 5-YEAR Echo and PARTNER II Quality of Life

How Much Radiation Do I Use Compared to Others? Review of Reference Levels and QA Policies

Hot: Is High Dose Due to Operator Preferences or Patient Characteristics?

Ethics of Irradiating Patients and Staff

PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Strengths and Limitations of Post-Approval Registries as Vehicles to Track Safety and Inform Device Label Expansion

Risk Scores: Development, Validation, Utility, and Limitations (With Case Studies: Framingham, TIMI/GRACE, CHADS/HASBLED, DAPT, and Others)

Mediation Analysis: A Method to Assign Attributable Risk

Surrogate Endpoints: Construction, Validation, and Trustiness

Accounting for the Risk of Competing Events

Analyzing Repeat Events

Limitations of Composite Endpoints and Strategies for Hierarchical Testing

Strengths and Limitations of Meta-analysis: Standard, Network and Bayesian Techniques, and the Value of Individual Patient-level Data Pooling

When Are Randomized Trials Not Enough, and Can Observational Data Reliably Inform Comparative Effectiveness Decisions?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content